View drug registration information details.
| Items | Registration information |
|---|
| ID | 2902 |
|---|
| No | 2902 |
|---|
| Brand Name | ZEPOSE 150 MG |
|---|
| Ingredients | IRBESARTAN 150 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-ALU BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 2 X 7'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF HYPERTENSION, OF DIABETIC NEPHROPATHY WITH AN ELEVATED SERUM CREATININE AND PROTEINURIA IN PATIENT WITH TYPE 2 DIABETES AND HYPERTENSION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | A WHITE, ROUND, "W" ENGRAVED ON ONE SIDE AND OTHER SIDE, PLAIN UNCOATED TABLET. |
|---|
| Note | |
|---|
| License Owner | VIMPEX (LAO) CO.,LTD |
|---|
| Manufacturer | WILSHIRE LABORATORIES(PVT) LTD |
|---|
| Country | PAKISTAN |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 I 4627/18 |
|---|
| FDD Registration Date | 26-SEP-2022 |
|---|
| Expiry Date | 25-SEP-2025 |
|---|
Back to drug list
|
